Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond

Chronic inflammation poses a major health risk by impairing tissue repair and organ function. While acute inflammation is a protective response, its prolonged activation can lead to tissue damage. Prior research has shown that pro-resolving mediators help limit inflammation and promote healing. However, the precise mechanisms by which these mediators act remain unclear. This gap motivated a deeper investigation into the signaling pathways involved in inflammation resolution. No prior work had resolved the full range of lipoxin-mediated interactions with multiple receptors. Understanding these interactions could clarify how inflammation is controlled at the molecular level. The role of ALX/FPR2 in this process has been studied, but its complexity is not fully understood. This review aims to synthesize current knowledge on lipoxin signaling and its implications for inflammation resolution.

This review aims to clarify the mechanisms by which lipoxins contribute to inflammation resolution. The focus is on ALX/FPR2 and alternative receptors involved in this process. The study addresses the biological complexity of these interactions and their implications for tissue healing. The goal is to provide a comprehensive overview of lipoxin signaling pathways. The authors seek to highlight the diversity of cellular responses triggered by lipoxins. This includes interactions with receptors beyond ALX/FPR2. The review also explores how these signaling pathways prevent chronic inflammation. The ultimate aim is to inform future research on inflammation resolution strategies.

The authors conducted a literature review of studies on lipoxin signaling. They analyzed interactions between lipoxins and various receptors, including ALX/FPR2 and cytoplasmic aryl hydrocarbon receptor. The review included data on intracellular signaling pathways triggered by these interactions. The authors synthesized findings from multiple experimental models. They examined the role of G-protein-coupled receptors in mediating cellular responses. The study also considered alternative receptors like cysteinyl-leukotriene receptors. The authors evaluated how these pathways contribute to inflammation resolution. The review approach focused on mechanisms rather than individual cell types.

Lipoxins interact primarily with ALX/FPR2, a G-protein-coupled receptor. These interactions trigger anti-inflammatory and pro-resolving effects in immune cells. The review found that lipoxins also bind to alternative receptors like GPR32. This binding activates distinct intracellular signaling pathways. The cytoplasmic aryl hydrocarbon receptor is another target of lipoxin action. These interactions suggest diverse mechanisms for inflammation resolution. The study highlights the role of lipoxins in preventing chronic pathologies. The findings indicate that lipoxin signaling is more complex than previously understood.

The authors propose that lipoxins use multiple receptors to resolve inflammation. ALX/FPR2 remains a primary mediator of these effects. Alternative receptors like aryl hydrocarbon receptor expand the signaling repertoire. This complexity allows lipoxins to modulate diverse cellular responses. The review suggests that lipoxin signaling prevents chronic inflammation. The findings support the idea that these mediators are crucial for tissue healing. The authors emphasize the need for further research into receptor-specific functions. They conclude that lipoxin-mediated pathways are essential for maintaining organ function.